Update on the recall of Philips CPAP/BiPAP

According to the latest information released by Philips on the official website in November 2021, Philips updated the guidance in its June 14, 2021 U.S. recall notifications to align them with FDA’s recommendations in connection with these recalls. They have not yet provided all the information needed for the FDA to evaluate the plan to repair and replace products across all the Philips Respironics’ recalled devices. Therefore the recall is still pending.

In order to enable you to continue using the CPAP/BiPAP, AMED will follow up with Philips on the arrangement of the parts replacement, and we provide a special trade-in program for designated customers. From now until 31st January, 2022, with Philips’ recalled models, designated customers can enjoy a 30% discount for the following models:

$12800 $8960

$20800 $14560

The offer is subject to relevant terms and conditions, please contact us for details

•  This plan is only for designated customers
•  Customers using this plan must trade-in the affected Philips models purchased from our company to enjoy this offer

•  No nasal mask included in this plan

•  Available for purchase from now until January 31, 2022
•  This plan cannot be used in conjunction with other discounts
•  AMED reserves the rights to change the preferential rules at any time and the right of final decision without prior notice